menu
    • menu

    Company profile for Aerovate Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's lead program is a potentially disease modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH). AV-101 is a proprietary inhaled dry powder formulation of the drug imatinib that delivers this medicine directly to diseased lung t...
    Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's lead program is a potentially disease modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH). AV-101 is a proprietary inhaled dry powder formulation of the drug imatinib that delivers this medicine directly to diseased lung tissues while reducing systemic adverse side effects. Aerovate was founded and incubated by RA Capital Management, a multi-stage investment manager focused on healthcare and life sciences.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aerovate TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    930 Winter Street, Suite M-500 Waltham, MA 02451
    Telephone
    Telephone
    617-443-2400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aerovatetx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Jade Biosciences Completes Merger with Aerovate Therapeutics
    Jade Biosciences Completes Merger with Aerovate Therapeutics

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069370/0/en/Jade-Biosciences-Completes-Closing-of-Merger-with-Aerovate-Therapeutics-and-Previously-Announced-Private-Placement-of-Approximately-300-Million.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Aerovate Stockholders Approve Merger with Jade Biosciences
    Aerovate Stockholders Approve Merger with Jade Biosciences

    21 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aerovate-therapeutics-stockholders-approve-proposed-merger-with-jade-biosciences-and-all-related-proposals-302433012.html

    PR NEWSWIRE
    21 Apr 2025
    Share Share
    Aerovate & Jade Biosciences Announce Merger Agreement
    Aerovate & Jade Biosciences Announce Merger Agreement

    31 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/31/2972454/0/en/Aerovate-Therapeutics-and-Jade-Biosciences-Announce-Merger-Agreement.html

    GLOBENEWSWIRE
    31 Oct 2024
    Share Share
    Aerovate Therapeutics to Explore Strategic Alternatives
    Aerovate Therapeutics to Explore Strategic Alternatives

    08 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/08/2909566/0/en/Aerovate-Therapeutics-to-Explore-Strategic-Alternatives.html

    GLOBENEWSWIRE
    08 Jul 2024
    Share Share
    Aerovate's stock plummets after sole product fails in PAH trial
    Aerovate's stock plummets after sole product fails in PAH trial

    18 Jun 2024

    // Zoey Becker FIERCE PHARMA

    https://www.fiercepharma.com/pharma/aerovate-therapeutics-shares-plummet-after-inhaled-version-novartis-gleevac-misses-phase-2b

    Zoey Becker FIERCE PHARMA
    18 Jun 2024
    Share Share
    Aerovate Presents IMPAHCT Phase 2b Baseline Data At ATS 2024
    Aerovate Presents IMPAHCT Phase 2b Baseline Data At ATS 2024

    21 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/21/2886042/0/en/Aerovate-Therapeutics-Presents-Baseline-Data-from-the-Phase-2b-Portion-of-the-IMPAHCT-Trial-at-the-American-Thoracic-Society-2024-International-Conference.html

    GLOBENEWSWIRE
    21 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search